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ATP analogs substituted in the g-phosphorus (ATPgS, b,g-
imido-ATP, and b,g-methylene-ATP) were used to probe the
involvement of P2 receptors in the modulation of synaptic
transmission in the hippocampus, because their extracellular
catabolism was virtually not detected in CA1 slices. ATP and
g-substituted analogs were equipotent to inhibit synaptic trans-
mission in CA1 pyramid synapses (IC50 of 17–22 mM). The
inhibitory effect of ATP and g-phosphorus-substituted ATP an-
alogs (30 mM) was not modified by the P2 receptor antagonist
suramin (100 mM), was inhibited by 42–49% by the ecto-59-
nucleotidase inhibitor and a,b-methylene ADP (100 mM), was
inhibited by 74–85% by 2 U/ml adenosine deaminase (which
converts adenosine into its inactive metabolite-inosine), and
was nearly prevented by the adenosine A1 receptor antagonist
1,3-dipropyl-8-cyclopentylxanthine (10 nM). Stronger support
for the involvement of extracellular adenosine formation as a
main requirement for the inhibitory effect of ATP and
g-substituted ATP analogs was the observation that an inhibitor
of adenosine uptake, dipyridamole (20 mM), potentiated by
92–124% the inhibitory effect of ATP and g-substituted ATP
analogs (10 mM), a potentiation similar to that obtained for 10
mM adenosine (113%). Thus, the present results indicate that
inhibition by extracellular ATP of hippocampal synaptic trans-
mission requires localized extracellular catabolism by ecto-
nucleotidases and channeling of the generated adenosine to
adenosine A1 receptors.
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ATP is currently recognized as a neurotransmitter and a neuro-
modulator in the nervous system (for review, see Zimmermann,
1994). In the hippocampus, ATP is released on stimulation (Ter-
rian et al., 1989; Cunha et al., 1996a; Wieraszko, 1996) and is a
potent inhibitor of hippocampal neuronal excitability (Lee et al.,
1981; Stone and Cusack, 1989; Cunha et al., 1996b). ATP may
directly control neuronal activity either by activating hippocam-
pal P2 receptors (Kidd et al., 1995; Collo et al., 1996; Inoue et al.,
1996) or by acting as a substrate of ecto-protein kinase during
synaptic plasticity phenomena (Wieraszko, 1996). ATP may also
indirectly modulate neuronal excitability after its extracellular
catabolism by the ecto-nucleotidase cascade (Lee et al., 1981;
Cunha et al., 1992), generating adenosine that modulates synaptic
transmission through inhibitory adenosine A1 receptors or facili-
tatory A2A receptors (Cunha et al., 1994a).
The proposal that P2 receptors are involved in the modulation
of synaptic transmission mostly relies on the use of metabolically
stable ATP analogs (Fredholm et al., 1994). However, it has been
proposed that metabolically stable ATP analogs may inhibit neu-
rotransmission either through direct action on inhibitory adeno-
sine A1 receptors (Hourani et al., 1991; Bailey et al., 1992; Piper
and Hollinsworth, 1996) or indirectly after their localized catab-
olism into adenosine (Bruns, 1990; Cascalheira and Sebastia˜o,
1992).
In the present work we investigated the relationship between
the effects of ATP analogs on synaptic transmission in the hip-
pocampus and their extracellular catabolism in this preparation.
We observed a mismatch between the absence of extracellular
catabolism of g-substituted ATP analogs in CA1 slices with the
modification of the inhibitory effect of g-substituted ATP analogs
by inhibitors of extracellular purinergic metabolism. This lead us
to conclude that g-substituted ATP analogs might undergo
minute localized catabolism into adenosine, and this adenosine is
channeled to adenosine A1 receptors. It is suggested therefore
that the possibility of mechanisms of preferential substrate deliv-
ery between ecto-nucleotidases and adenosine receptors ought to
be taken into account and tested through functional assays using
modulators of purine metabolism whenever effects of apparently
stable adenine nucleotides are observed. This might be of partic-
ular relevance when the actions of adenine nucleotides do not
easily fit to P2X or P2Y receptor-mediated actions.
MATERIALS AND METHODS
ATP, ADP, AMP, adenosine, adenosine-59-O-(a,b-methylene)-
diphosphonate sodium salt (AOPCP), b,g-imido ATP tetralithium salt
(b,g-imido-ATP), b,g-methylene ATP sodium salt (b,g-methylene-ATP),
a,b-methylene ATP dilithium salt (a,b-methylene-ATP), adenosine 59-O-
(3-thio)-triphosphate tetralithium salt (ATPgS), 29-deoxyadenosine, 29-
deoxyadenosine-59-triphosphate (29-dATP), p-nitrophenylphosphate, hy-
poxanthine, and inosine were from Sigma (St. Louis, MO). Adenosine
deaminase (type VI, 1803 U/ml, EC 3.5.4.4) was also purchased from
Sigma, in a suspension in 50% (vol/vol) glycerol in potassium phosphate,
pH 6.0, and dilutions of this suspension were used, together with appropri-
ate corrections of glycerol and KH2PO4 content of all control solutions.
2-Methylthio-ATP tetrasodium salt (2-methylthio-ATP), 1,3-dipropyl-8-
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cyclopentylxanthine (DPCPX), suramin, reactive blue 2, and pyridoxal-
phosphate-6-azophenyl-29,49-disulfonic acid (PPADS) were from RBI
(Natick, MA). 2-Methylthio-ADP trilithium salt and 2-methylthio-AMP
dilithium salt were from Boehringer Mannheim (Indianapolis, IN), and
dipyridamole was from Boehringer Ingelheim. KH2PO4 (Aristar) was from
BDH Chemicals (Poole, UK), methanol (Chromosolv) was from Riedel,
and tetrabutylammonium (PIC-A) was from Waters Associates (Milford,
MA). All other reagents were of the highest purity available.
All nucleotide stock solutions were made up into a 5 mM stock solution
in water. Because most commercially available ATP analogs are contam-
inated (up to 5%) by ATP, ADP, and other unidentified substances, ATP
analogs (except 29-dATP) were separated by HPLC (as described below)
before their use in electrophysiological or kinetic experiments. It was
observed (data not shown) that the HPLC eluent did not affect synaptic
transmission or ATP catabolism in CA1 hippocampal synaptosomes.
DPCPX was made up into a 5 mM stock solution in 99% dimethylsul-
foxide/1% NaOH (1 M) (vol /vol). Dipyridamole was made up into a 5 mM
dimethylsulfoxide solution. All stock solutions were stored as frozen
aliquots at 220°C. Aqueous dilutions of these stock solutions were made
daily and appropriate solvent controls were performed. The pH of the
superfusion solution did not change by the addition of the drugs in the
maximum concentrations used.
Electrophysiolog ical recordings of synaptic transmission. Rat hippocam-
pal slices (400 mm thick) were prepared (Cunha et al., 1994a) and allowed
to recover for 1 hr at room temperature in artificial cerebrospinal fluid of
the following composition (in mM): NaCl 124, KCl 3, KH2PO4 1.25,
MgSO4 1, CaCl2 2, NaHCO3 26, glucose 10, pH 7.4, gassed with a 95%
O2 and 5% CO2 mixture. One slice was transferred to a 1 ml recording
chamber for submerged slices and superfused continuously with gassed
artificial cerebrospinal fluid, kept at 30.5°C, at a flow rate of 3 ml/min.
Drugs were added to this superfusion solution.
Electrophysiological recordings of field EPSPs (fEPSPs) were obtained
as described previously (Cunha et al., 1994a). Monopolar stimulation
(rectangular pulses of 0.1 msec applied once every 10 sec) was delivered
through an electrode placed on the Schaffer fibers, in the stratum radia-
tum near the CA3/CA1 border. Orthodromically evoked fEPSPs were
recorded through an extracellular microelectrode (4 M NaCl, 2–6 MV
resistance) placed in the stratum radiatum of the CA1 area. The intensity
of the stimulus (130–310 mA) was adjusted to evoke the largest fEPSP
without population spike contamination. The individual responses were
displayed on a Tektronix (2430A) oscilloscope, and the averages of eight
consecutive responses were digitally recorded. fEPSP responses were
quantified as the initial slope of the averaged fEPSPs. Perfusion of a slice
with any tested drugs was started after a stable response was recorded.
When concentration response curves for ATP analogs were per-
formed, each compound was added in increasing concentrations in a
cumulative manner, followed by washout. When the ability of a given
substance to modify the effect of ATP analogs was tested, ATP analogs
were first tested in the absence of the substance, the substance was then
applied to the preparation for at least 30 min, and the effect of the ATP
analogs was then tested in the presence of the substance. Usually the
substance was washed out, and the effect of ATP analogs was tested again
in the absence of the substance.
Extracellular catabolism of ATP analogs in CA1 slices. Slices from the CA1
area were manually dissected (Cunha et al., 1994b) and allowed to recover
for 1 hr at room temperature in artificial cerebrospinal fluid gassed with a
95% O2 and 5% CO2 mixture. Groups of three CA1 slices were then
transferred to incubation vials with 500 ml of Krebs’ solution of the follow-
ing composition (in mM): NaCl 125, KCl 3, KH2PO4 1.25, MgSO4 1, CaCl2
2, HEPES 25, glucose 10, pH 7.4, kept at 30.5°C under continuous orbital
swirling. After 10 min incubation, the initial substrate, i.e., ATP or an ATP
analog, was added at a final concentration of 30 mM. The kinetic protocols
consisted of a 20 min incubation period with sample collection (50 ml) at 0,
1, 2, 5, 10, 15, and 20 min. The zero time was defined as the sample
collected immediately after (;2–5 sec) addition of the initial substrate. The
samples were stored on ice and analyzed by HPLC. After the incubation,
the remaining bathing solution was removed, and the slices were homoge-
nized in 200 ml of 2% (vol/vol) Triton X-100 to determine total lactate
dehydrogenase activity and protein content. Lactate dehydrogenase activ-
ity, an index of cellular disruption (Cunha et al., 1992), was quantified in the
bathing solution and was always lower than 2% of total lactate dehydroge-
nase activity in the CA1 slices.
Extracellular catabolism of adenine nucleotides in CA1 synaptosomes.
Synaptosomes from the CA1 area were obtained from homogenized,
manually dissected CA1 slices by a sucrose–Percoll method (Cunha et
al., 1992). Aliquots of 100 ml of the synaptosomes (resuspended in 800 ml
of Krebs’ solution) were then added to incubation vials with 400 ml of
Krebs’ solution kept at 30.5°C. After a 10 min incubation, the initial
substrate, i.e., ATP, or an ATP analog, or AMP in the presence of ATP
analogs, was added at a final concentration of 30 mM. The kinetic
protocols were identical to these described for CA1 slices. Each collected
sample was centrifuged (14,000 3 g for 15 sec) in a refrigerated centri-
fuge (4°C), and the supernatant (50 ml) was stored on ice for HPLC
analysis. After the 20 min incubation, the synaptosomes were pelleted by
centrifugation (14,000 3 g for 15 sec) in a refrigerated centrifuge (4°C).
The pelleted synaptosomes were homogenized in 200 ml of 2% (vol /vol)
Triton X-100 to determine total lactate dehydrogenase activity and
protein content. The remaining bathing solution was used to quantify
lactate dehydrogenase activity, which was always lower than 3% of total
lactate dehydrogenase activity in the CA1 synaptosomes.
HPLC analysis. Separation of nucleotides and their degradation prod-
ucts was performed by ion-pair reverse-phase HPLC analysis of nonex-
tracted samples (20 ml) as described previously (Cascalheira and Sebas-
tia˜o, 1992), with minor modifications, using a Beckman 126 solvent
delivery module equipped with a 210A sample injection valve with a 20
ml loop coupled with a Beckman 166 UV detector set at 254 nm, both
connected to a Compaq 286e computer using the Gold software package.
Separations were performed at room temperature with LiChrospher 100
RP-18 (5 mm) cartridges (Merck, Darmstadt, Germany) fitted into a
Manu-cart holder (Merck). The columns were protected by LiChrospher
60 RP-select B (5 mm) pre-columns (Merck). The eluent, pH 6.0, was
composed of KH2PO4 60 mM, tetrabutylammonium 5 mM, and 5–35%
(vol /vol) methanol. A 10 min linear gradient from 5 to 35% (vol /vol)
methanol was performed, starting after sample injection, with a constant
flow rate of 1.5 ml/min. Under these conditions, the retention times of
the substances used as standards were as follows: hypoxanthine (1.2 min),
inosine (1.7 min), adenosine (3.6 min), AMP (4.7 min), AOPCP (5.8
min), ADP (6.8 min), a,b-methylene-ATP (7.8 min), b,g-imido-ATP (7.9
min), b,g-methylene-ATP (8.0 min), ATP (8.3 min), 2-methylthio-AMP
(9.8 min), ATPgS (10.7 min), 2-methylthio-ADP (10.9 min), and
2-methylthio-ATP (11.6 min). Linear calibration curves were obtained
for each substance after electronic integration of the peak area for each
substance (1–1000 pmol in 20 ml injected). Identification of the peaks was
performed by comparison of relative retention times with standards.
Kinetic analysis. The concentrations of the products at the different
times of sample collection were corrected by subtracting the concentra-
tions of products eventually present at zero time. The concentration of
products, in samples collected from the same batch of slices or synapto-
somes, incubated without adding substrate, were also subtracted for
correction of spontaneous release. Plots of concentration of the substrate
and products as a function of time (progress curves) were constructed.
The relative extent of catabolism of ATP analogs was compared by
calculating the amount of substrate catabolized after 20 min. The specific
activity of ecto-ATPase activity in hippocampal preparations was calcu-
lated by linear regression of the decrease of the amount of extracellular
ATP during the first 5 min of catabolism, normalized per milligram of
protein. To test the effects of p-nitrophenylphosphate on the catabolism
of ATP analogs, progress curves of ATP analogs were performed in
parallel batches of slices or synaptosomes from the same group of
animals, one in the absence and the other in the presence of
p-nitrophenylphosphate (1 mM).
The extracellular catabolism of AMP in the presence of ATP analogs
was analyzed as described previously (Cunha et al., 1992).
Other determinations. Lactate dehydrogenase (EC 1.1.1.27) activity was
assayed by the method of Keiding et al. (1974). Protein concentration of
the slices and of the synaptosomes was determined by the Bradford
method, modified according to Spector (1978).
Statistical calculations. The values are presented as mean 6 SEM, with
n being the number of animals or different groups of animals used. The
significance of the differences between the means was calculated by a
one-way ANOVA followed by a paired Student’s t test or a Dunnett’s
test. p values of ,0.05 were considered to represent significant
differences.
RESULTS
Effects of ATP analogs on hippocampal
synaptic transmission
ATP, in the micromolar range, inhibited in a concentration-
dependent manner the fEPSP slope in stimulated CA1 pyramid
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synapses, with an IC50 of 20 6 3 mM (n 5 4) and was slightly less
potent than adenosine (IC50 of 12 6 2 mM; n 5 4). ATP analogs
substituted in the g-phosphorus also inhibited synaptic transmis-
sion in a concentration-dependent manner (Fig. 1); the IC50
values were 17 6 3 mM (n 5 4) for ATPgS, 22 6 5 mM (n 5 4) for
b,g-imido-ATP, and 20 6 2 mM (n 5 4) for b,g-methylene-ATP.
a,b-methylene-ATP, an ATP analog substituted in the
a-phosphorus, was less potent than ATP (Fig. 1), with a maximal
inhibition of 19 6 2% at 60 mM (n 5 4; p , 0.05). ATP analogs
substituted in the purine moiety, namely in the ribose ring, such
as 2-methylthio-ATP (Fig. 1), were also less potent than ATP,
with a maximum inhibition of 25 6 5% at 60 mM (n 5 4; p , 0.05),
or even devoid of effects, such as 29-dATP (10–100 mM; n 5 2).
As shown in Figure 2, the inhibitory effect of ATP and of ATP
analogs (30 mM) was not modified (n 5 2–3) by the P2 receptor
antagonist suramin (100 mM). The inhibitory effect of ATP and of
g-phosphorus-substituted ATP analogs was also virtually unaf-
fected by the P2 receptor antagonists, reactive blue 2 (30 mM; n 5
2), or PPADS (30 mM; n 5 1). By itself, suramin (100 mM; n 5 3),
reactive blue 2 (30 mM; n 5 2), and PPADS (30 mM; n 5 1) caused
a 16 6 1%, 21 6 4%, and 15% inhibition of fEPSP slope,
respectively.
In contrast, the inhibitor of ecto-59-nucleotidase, AOPCP (100
mM), inhibited by 42–49% (n 5 3) the inhibitory effect of ATP
and g-substituted ATP analogs (Fig. 2). This effect was not
attributable to any effect of AOPCP per se on purine receptors
because the inhibitory effect of adenosine (30 mM) was not mod-
ified by 100 mM AOPCP (n 5 3). As described previously (Cunha
et al., 1996b), AOPCP (100 mM) by itself caused a 18 6 2%
inhibition of fEPSP slope (n 5 3).
That the effect of ATP and g-phosphorus-substituted ATP
analogs depended mainly on the formation of extracellular aden-
osine was also supported by the observation that adenosine
deaminase (2 U/ml), which converts adenosine into its inactive
metabolite inosine, inhibited by 74–85% (n 5 3–4) the inhibitory
effect of ATP and g-substituted ATP analogs (30 mM) (Fig. 2). By
itself, adenosine deaminase (2 U/ml) caused a 23 6 2% increase
of fEPSP slope (n 5 4), which is compatible with an inhibitory
“tonus” by endogenous adenosine (Cunha et al., 1996b).
The requirement for activation of inhibitory adenosine A1
receptors to observe the inhibitory effect of ATP and
g-phosphorus-substituted ATP analogs was suggested from the
observation that 10 nM DPCPX, an adenosine A1 receptor antag-
onist that blocks the inhibitory effect of maximally effective
concentrations of 2-chloroadenosine in the hippocampus (Sebas-
tia˜o et al., 1990), inhibited by 80–93% (n 5 3–4) the inhibitory
effect of ATP and g-substituted ATP analogs (30 mM) (Fig. 2). By
itself, DPCPX (10 nM) caused a 19 6 3% increase of fEPSP slope
(n 5 4).
Stronger support for the involvement of extracellular adeno-
sine formation as a main requirement for the inhibitory effect of
ATP and g-substituted ATP analogs was derived from the obser-
vation that dipyridamole (20 mM), which supramaximally inhibits
adenosine uptake (Morgan and Marangos, 1987), potentiated the
inhibitory effect of ATP and g-phosphorus-substituted ATP ana-
logs (10 mM) (Fig. 3). Thus, dipyridamole (20 mM) potentiated by
92–124% (n 5 3–4) the inhibitory effect of ATP and g-substituted
ATP analogs (10 mM), and it potentiated the inhibitory effect of
adenosine (10 mM) by a similar amount (113 6 26%; n 5 4). By
itself, dipyridamole (20 mM) caused a 30 6 5% inhibition of
fEPSP slope (n 5 4), probably by the ability of dipyridamole to
increase the endogenous levels of extracellular adenosine (Mitch-
ell et al., 1993).
The small inhibitory effect of a,b-methylene-ATP (30 mM) was
more potently inhibited (65 6 5%; n 5 3) by 100 mM AOPCP than
the inhibitory effect of g-phosphorus-substituted ATP analogs,
less inhibited by 10 nM DPCPX (60 6 5%; n 5 3), and completely
prevented (n 5 2) by 2 U/ml adenosine deaminase (Fig. 2). The
potentiation of the inhibitory effect of a,b-methylene-ATP (10
mM) by 20 mM dipyridamole (32 6 15%; n 5 3) was also lower
than that observed for g-phosphorus-substituted ATP analogs
(Fig. 2).
The small inhibitory effect of 2-methylthio-ATP (30 mM) was
also less inhibited by 2 U/ml adenosine deaminase (44 6 5%; n 5
3) and by 10 nM DPCPX (67 6 6%; n 5 2) than the inhibitory
effect of g-phosphorus-substituted ATP analogs and was not con-
sistently modified by 100 mM AOPCP (n 5 3) or by 20 mM
dipyridamole (n 5 3) (Fig. 2).
Catabolism of ATP analogs in hippocampal CA1 slices
and synaptosomes
As shown in Figure 4A, extracellular ATP (30 mM) was catabo-
lized by hippocampal CA1 slices (0.75 6 0.02 mg protein), with a
half-degradation of 8 6 2 min (n 5 5). The ATP metabolites
detected in the bath were ADP, the concentration of which
reached a maximum of 7 6 2 mM at 10 min; AMP, the concen-
tration of which reached a maximum of 9 6 1 mM at 15 min; and
adenosine, the maximum concentration of which (12.5 6 0.9 mM)
was reached at 20 min.
The catabolism of ATP (30 mM) showed a similar pattern in
hippocampal CA1 synaptosomes (2.6 6 0.2 mg protein; n 5 4),
with a half-degradation time of 0.8 6 0.1 min. The ATP metab-
olites detected in the bath were ADP, the concentration of which
reached a maximum of 10 6 1 mM at 1 min; AMP, the concen-
tration of which reached a maximum of 11 6 2 mM at 10 min; and
adenosine, the concentration of which reached a maximum of
17 6 3 mM at 15 min (Fig. 4B).
Surprisingly, the extent of catabolism of g-phosphorus-
substituted ATP analogs (30 mM) was not significant in hippocam-
Figure 1. Inhibition of the fEPSP slope, recorded extracellularly in
hippocampal CA1 pyramids, by exogenously added adenosine (E), ATP
(F), ATPgS (f), b,g-imido-ATP (M), b,g-methylene-ATP (),
2-methylthio-ATP (), and a,b-methylene-ATP (). The ordinates rep-
resent the percentage of inhibition of fEPSP slope produced by adenosine,
ATP, or ATP analogs in relation to the fEPSP slope in control conditions
(i.e., in the absence of any added drug to the perfusion solution). 0%
corresponds to the fEPSP slope in control conditions (i.e., without any
added drug), and 100% corresponds to blockade of fEPSP. The results are
mean 6 SEM of two to five experiments. The SEMs are shown when they
exceed the symbols in size.
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pal CA1 slices (n 5 5). The concentration of these ATP analogs
did not change significantly during the 20 min incubation period,
nor did any purine metabolite appear in the bath in measurable
amounts (Fig. 4C–E).
In contrast, g-phosphorus-substituted ATP analogs (30 mM)
were catabolized in hippocampal CA1 synaptosomes (Fig. 4C–
E). After 20 min, 5.1 6 0.5 mM ATPgS had been catabolized
(n 5 4), and 1.0 6 0.1 mM AMP appeared in the bath; 3 6 1 mM
b,g-imido-ATP had been catabolized (n 5 4), and 0.8 6 0.1 mM
AMP appeared in the bath after 20 min; and 4.0 6 0.2 mM
b,g-methylene-ATP had been catabolized (n 5 4), and 1.0 6
0.2 mM AMP appeared in the bath after 20 min. In hippocam-
pal CA1 synaptosomes, when ATPgS, b,g-imido-ATP, or b,g-
methylene-ATP were assayed as initial substrates, ADP never
appeared in the bath in measurable amounts. The presence of
p-nitrophenylphosphate (1 mM) did not appreciably change the
amounts of ATPgS, b,g-imido-ATP or b,g-methylene-ATP
catabolized after 20 min, nor did p-nitrophenylphosphate ap-
preciably change the amounts of AMP formed as a result of
g-phosphorus-substituted ATP analogs (30 mM) catabolism.
When a,b-methylene-ATP (30 mM) was used as initial sub-
strate, the only metabolite appearing in the bath was AOPCP,
which reached a maximum concentration of 10.4 6 0.7 mM in
CA1 slices (n 5 5) and 13 6 1 mM in CA1 synaptosomes (n 5
4) (Fig. 4 F).
2-Methylthio-ATP (30 mM) was catabolized in both CA1 slices
(Fig. 4G) and CA1 synaptosomes (Fig. 4H). During the 20 min
incubation period, 9.3 6 0.6 mM and 13.9 6 0.6 mM 2-methylthio-
ATP were catabolized in both CA1 slices (n 5 5) and synapto-
somes (n 5 4), respectively. 2-Methylthio-ATP was converted
into 2-methylthio-ADP and 2-methylthio-AMP and in another
nonidentified product with a retention time of 7.9 min, which
might correspond to 2-methylthio-adenosine, although no stan-
dard is commercially available to identify this peak (Fig. 4G,H).
Figure 2. Modification of the inhibition by adenosine, ATP, and ATP analogs of fEPSPs by 100 mM suramin, a P2 receptor antagonist (A), by 100 mM
a,b-methylene ADP (AOPCP), an inhibitor of ecto-59-nucleotidase (B), by 2 U/ml adenosine deaminase (ADA), the enzyme that converts adenosine into
its inactive metabolite, inosine ( C), by 10 nM 1,3-dipropyl-8-cyclopentylxanthine (DPCPX), an adenosine A1 receptor antagonist (D), and by 20 mM
dipyridamole, an inhibitor of adenosine uptake ( E). The ordinates represent the percentage inhibition of fEPSP slope by adenosine or ATP, ATPgS (gS),
b,g-imido-ATP (b,g-Im), b,g-methylene-ATP (b,g-Me), a, b-methylene-ATP (abMe), and 2-methylthio-ATP (2MeS) in the absence (open bars) and
presence ( filled bars) of the drugs indicated in each panel. 0% corresponds to the fEPSP slope in control conditions (i.e., without any added drug or after
addition of suramin, AOPCP, adenosine deaminase, DPCPX, or dipyridamole), and 100% corresponds to blockade of fEPSPs. In each experiment, suramin,
AOPCP, adenosine deaminase, DPCPX, or dipyridamole were applied to the preparations 30–45 min before the effect of adenosine, ATP, or ATP analogs
was tested in their presence. The effect of adenosine, ATP, or ATP analogs in the absence and presence of suramin, AOPCP, adenosine deaminase,
DPCPX, or dipyridamole was always compared in the same experiment. * p , 0.05 (paired Student’s t test) when comparing with the effect of adenosine,
ATP, or ATP analogs alone. The results are mean 6 SEM of three to four experiments. The SEMs are shown when they exceed the symbols in size.
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The catabolism of AMP (30 mM) resulted in the formation of
adenosine, inosine, and hypoxanthine, as described previously
(Cunha et al., 1992). The rate of AMP catabolism during the first
5 min of incubation was decreased by 12–21% by a,b-methylene-
ATP (30 mM; n 5 2), and was not modified by ATPgS, b,g-imido-
ATP, or b,g-methylene-ATP (30 mM; n 5 2).
DISCUSSION
The present results show that the inhibition of synaptic trans-
mission in Schaffer fibers/CA1 pyramid synapses of rat hip-
pocampal slices by ATP and g-phosphorus-substituted ATP
analogs is mediated by activation of inhibitory A1 adenosine
Figure 3. Effect of the inhibitor of adenosine uptake, dipyridamole to potentiate the inhibitory effect of ATPgS (1), b,g-imido-ATP (2), b,g-methylene-
ATP (3), 2-methylthio-ATP (4), ATP (5), adenosine (6), and a,b-methylene-ATP (7 ) on fEPSP slope. In A is shown the time course of the slope of
averages of eight consecutive fEPSPs recorded from the CA1 area of the hippocampus. The hippocampal slice was perfused with adenosine, ATP, or ATP
analogs (10 mM) either in the absence or in the presence of dipyridamole (20 mM), as shown in the top bars. In B, C, and D are shown recordings of fEPSPs,
corresponding to the absence of any added drug in the perfusion medium (i in B, C, and D), the presence of ATP (B, ii), ATPgS (C, ii), and adenosine (D,
ii), the presence of dipyridamole (iii in B, C, and D), the simultaneous presence of dipyridamole and ATP (B, iv), the simultaneous presence of dipyridamole
and ATPgS (C, iv), and the simultaneous presence of dipyridamole and adenosine (D, iv). Each recording is composed of a stimulus artifact followed by
the presynaptic volley and the fEPSP and corresponds to the average of eight consecutive responses. Calibration bars (shown in B for B–D): 500 mV, 5 msec.
Note that dipyridamole (20 mM) potentiated to a similar extent the inhibitory effect of g-phosphorus-substituted ATP analogs (1, 2, and 3), ATP (5), and
adenosine (6), whereas the inhibitory effect of 2-methylthio-ATP ( 4) and a,b-methylene-ATP (7 ) was not modified appreciably.
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Figure 4. Progress curves of ATP and ATP analog catabolism in CA1 hippocampal slices and synaptosomes. ATP or ATP analogs (30 mM) were
incubated at zero time with CA1 slices or synaptosomes. Samples (50 ml) were collected from the bath (600 ml) at the times indicated in the abscissa
and analyzed by HPLC. In A is shown the catabolism of ATP (F) into ADP (f), AMP (), and adenosine () in CA1 slices. In B is shown the catabolism
of ATP (E) into ADP (M), AMP (), and adenosine () in CA1 synaptosomes. In C is shown the catabolism of ATPgS (Figure legend continues)
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receptors after extracellular catabolism of these nucleotides
into adenosine by ecto-nucleotidases. Thus, the inhibitory ef-
fect on synaptic transmission of ATP and g-substituted ATP
analogs was inhibited (1) by AOPCP, an inhibitor of ecto-59-
nucleotidase, the enzyme that forms adenosine from extracel-
lular adenine nucleotides, (2) by adenosine deaminase, which
converts adenosine into its inactive metabolite inosine, and (3)
by DPCPX, an adenosine A1 receptor antagonist, whereas
(4) it was potentiated by the adenosine uptake inhibitor
dipyridamole.
The inability of the nucleotide P2 receptor antagonists
suramin reactive blue 2 and PPADS to modify the inhibitory
effect of ATP and g-substituted ATP analogs further supports
the idea that extracellular catabolism of ATP and g-substituted
ATP analogs into adenosine is mainly responsible for this
inhibitory effect. We tested three chemically distinct P2 antag-
onists to exclude the possibility that diffusion barriers might
exist to access P2 receptors. It should be stressed, however, that
the possibility of P2 receptors having a role in the hippocampus
cannot be excluded. Indeed, P2 receptors are expressed in the
hippocampus (Kidd et al., 1995; Buell et al., 1996; Collo et al.,
1996), the effects of ATP on synaptic transmission in the
hippocampus are not completely prevented by pharmacological
tools interfering with adenosine neuromodulation (Lee et al.,
1981; Cunha et al., 1996b), and antagonists of P2 receptors
produce effects in hippocampal preparations (Motin and Ben-
nett, 1995), although they also directly affect ionotropic GABA
and glutamate receptors (Nakazawa et al., 1995) and modify
ecto-nucleotidase activity (Ziganshin et al., 1996). Also, P2
receptors insensitive to the commonly used P2 receptor antag-
onists have been described (Buell et al., 1996). Thus, it is
possible that at higher frequencies of stimulation, for instance,
P2 receptors may have a physiological role in modulating
synaptic transmission in the hippocampus, as has been shown
to occur with ecto-protein kinases (Wieraszko, 1996); although
at lower frequencies of stimulation, as used in the present
work, the effect of ATP is mostly mediated by A1 receptors
after extracellular catabolism into adenosine by ecto-
nucleotidases. Previous work also concluded that the absence
of P2 receptor-mediated modulation of transmission in Schaf-
fer fibers/CA1 pyramid synapses of rat hippocampal slices
based on the use of ATP analogs derived from the inactive
enantiomer of adenosine L-adenosine (Stone and Cusack,
1989).
The discrepancy between the stability of g-substituted ATP
analogs in an innervated skeletal muscle preparation and the
modification of their action on neuromuscular transmission by
modifiers of adenosine metabolism lead to the proposal of
localized catabolism of adenine nucleotides coupled to activa-
tion of inhibitory adenosine A1 receptors (Bruns, 1990; Cas-
calheira and Sebastia˜o, 1992). This discrepancy was also ob-
served in the present work, i.e., no measurable extracellular
metabolism of g-substituted ATP analogs seems to occur in
hippocampal slices, whereas the functional assays revealed an
adenosine-mediated action of these nucleotides. The channel-
ing of the product of ecto-nucleotidases activity, adenosine, to
A1 receptors allows us to understand how a very low rate of
catabolism of g-substituted ATP analogs might allow effective
activation of adenosine A1 receptors. Although very low
amounts of adenosine are formed, substrate channeling allows
a high local concentration of adenosine to be reached in the
surroundings of A1 receptors. This possibility, which was not
tested or considered in several studies on the physiological
effects mediated by extracellular ATP, has lead to the proposal
that g-substituted ATP analogs might directly activate adeno-
sine A1 receptors (Hourani et al., 1991; Bailey et al., 1992;
Piper and Hollingsworth, 1996), although binding studies show
that g-substituted ATP analogs are not effective displacers of
adenosine A1 receptor binding (Williams and Braunwalder,
1986). The existence of substrate channeling properties in the
delivery of adenosine formed from ecto-nucleotidases and the
existence of a strong gradient for extracellular adenosine in a
synapse (Cunha, 1997) could also explain the greater potency
of ATP and ATP analogs compared with that of adenosine to
inhibit neurotransmitter release or synaptic transmission (Si-
linsky and Ginsborg, 1983; Shinozuka et al., 1990; Cunha et al.,
1994c), which was the basis for proposing the existence of a P3
receptor (Shinozuka et al., 1990; Cunha et al., 1994c) (but see
Saitoh and Nakata, 1996). Thus, if adenosine is effectively
removed by the nucleoside transport system before reaching
adenosine A1 receptors and adenosine formed from extracel-
lular adenine nucleotides catabolism is preferentially delivered
to adenosine A1 receptor, it is conceivable that ATP deriva-
tives may have a greater potency than adenosine itself, al-
though both act via adenosine A1 receptor activation. Aware-
ness is growing (Harden et al., 1997) that to establish an effect
of ATP as such it is essential to show that removal of extra-
cellular adenosine, inhibition of the ecto-nucleotidase cascade,
and blockade of A1-mediated responses does not occlude ATP
effect. Only after the possibility is excluded that the effect of
ATP is not mediated by localized extracellular catabolism into
adenosine by the ecto-nucleotidase cascade will it be possible
to consider an effect mediated by ATP as such.
The extracellular catabolism of ATP by ecto-nucleotidases
was qualitatively similar in hippocampal CA1 slices and syn-
aptosomes, with the apparent sequential formation of ADP,
AMP, and adenosine. Quantitatively, the specific activity of
ATP catabolism was higher in synaptosomes than in slices, as
had been observed previously in a particular synaptosomal
fraction (Cunha and Sebastia˜o, 1992). ATP analogs with sub-
stitutions in g-phosphorus were also catabolized in CA1 syn-
aptosomes, but not in slices, although at a lower rate than ATP
catabolism. However, the extracellular catabolism of
g-phosphorus-substituted ATP analogs was different from that
4
(F, E) into AMP (,) in CA1 slices ( filled symbols, filled lines) and CA1 synaptosomes (open symbols, broken lines). In D is shown the catabolism of
b,g-imido-ATP (F, E) into AMP (,) in CA1 slices ( filled symbols, filled lines) and CA1 synaptosomes (open symbols, broken lines). In E is shown the
catabolism of b,g-methylene-ATP (F, E) into AMP (,) in CA1 slices ( filled symbols, filled lines) and CA1 synaptosomes (open symbols, broken lines).
In F is shown the catabolism of a,b-methylene ATP (F, E) into a,b-methylene ADP (l, L) in CA1 slices ( filled symbols, filled lines) and CA1
synaptosomes (open symbols, broken lines). In G is shown the catabolism of 2-methylthio-ATP (F) into 2-methylthio-ADP (f), 2-methylthio-AMP ()
and into an unidentified compound () in CA1 slices. In H is shown the catabolism of 2-methylthio-ATP (E) into 2-methylthio-ADP (M),
2-methylthio-AMP () and into an unidentified compound () in CA1 synaptosomes. Each point is the average of four to five experiments. The vertical
bars represent the SEM and are shown when they exceed the symbols in size. The concentrations of inosine and adenosine detected under control
conditions, without addition of initial substrate, were subtracted. The concentration of any purine metabolite present at time 0 was also subtracted.
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of ATP, because the only metabolite detected in the bath was
AMP, whereas ADP was never detected. This pattern would be
expected if an ecto-ATP pyrophosphatase (EC 3.6.1.8) instead
of an ecto-ATP diphosphohydrolase (Plesner, 1995) would be
catabolizing extracellular ATP, because the involvement of
nonspecific phosphatases was excluded on the basis of the
absence of effect of p-nitrophenylphosphate. The lack of com-
mercially available inhibitors of ecto-ATP pyrophosphatase
precludes direct testing of this hypothesis. The ability to detect
catabolism of ATP analogs in synaptosomes but not in slices
probably reflects a higher specific activity of catabolism of
g-substituted ATP analogs in synaptosomes. It is expected that
localized catabolism of g-substituted ATP analogs might occur
in the slices, because the synaptosomes were obtained from the
slices, but the rate of catabolism may be below detection limit.
It is interesting to note that ATP analogs substituted in the
a-phosphorus or in the purine ring displayed a functional behav-
ior distinct from that of g-substituted ATP analogs. Thus, the
modulators of adenosine metabolism/effects (adenosine deami-
nase, DPCPX) affected the action of a,b-methylene-ATP the
same as they modify the action of AOPCP in the hippocampus
(Cunha et al., 1996b). The observations that a long (30 min)
preincubation with a,b-methylene-ATP (100 mM) reduces the
inhibitory effect of ATP (30 mM) on synaptic transmission by
16–21% (n 5 2; data not shown) and that a,b-methylene-ATP
(30 mM) inhibited extracellular AMP catabolism further supports
the possibility that the effect of this a-substituted ATP analog is
caused by direct or indirect (after conversion into AOPCP)
(compare Fig. 4F) inhibition of ecto-59-nucleotidase. Although
presynaptic inhibition of neurotransmitter by activation of P2Y
receptors has been proposed (von Ku¨gelgen, 1996), the effect of
2-methylthio-ATP, which was smaller than that of the other ATP
analogs, is currently difficult to interpret with the biochemical and
pharmacological approaches used.
In conclusion, the present results demonstrate that ATP and
g-phosphorus-substituted ATP analogs have to be extracellu-
larly converted into adenosine to exert their inhibitory effects
on synaptic transmission in the hippocampus, and they high-
light the importance of channeling adenosine to adenosine A1
receptors as a means for adenine nucleotides to inhibit synap-
tic transmission.
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